6U8O

Discovery and optimization of salicyclic acid-derived sulfonamide inhibitors of the WDR5:MYC protein-protein interaction

Summary for 6U8O

• Entry DOI: 10.2210/pdb6u8o/pdb
• Descriptor: WD repeat-containing protein 5, 5-bromo-N-[5-(1-cyanocyclobutyl)-2-hydroxyphenyl]-2-hydroxybenzene-1-sulfonamide (3 entities in total)
• Functional Keywords: wdr5, myc, rbbp5, structure-based design, high-throughput screening, transcription
• Biological source: Homo sapiens (Human)
• Total number of polymer chains: 1
• Total formula weight: 33915.30

Authors

Zhao, B.,Wang, F. (deposition date: 2019-09-05, release date: 2019-12-04, Last modification date: 2023-10-11)

• Primary citation: Macdonald, J.D.,Chacon Simon, S.,Han, C.,Wang, F.,Shaw, J.G.,Howes, J.E.,Sai, J.,Yuh, J.P.,Camper, D.,Alicie, B.M.,Alvarado, J.,Nikhar, S.,Payne, W.,Aho, E.R.,Bauer, J.A.,Zhao, B.,Phan, J.,Thomas, L.R.,Rossanese, O.W.,Tansey, W.P.,Waterson, A.G.,Stauffer, S.R.,Fesik, S.W.; Discovery and Optimization of Salicylic Acid-Derived Sulfonamide Inhibitors of the WD Repeat-Containing Protein 5-MYC Protein-Protein Interaction.; J.Med.Chem., 62:11232-11259, 2019; PubMed: 31724864; DOI: 10.1021/acs.jmedchem.9b01411

Experimental method

X-RAY DIFFRACTION (1.6 Å)